Biopharmaceuticals
Oncology
Regulatory
News Release - July 21, 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Source: Merck KGaA
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.